Decision Sciences Medical

Decision Sciences Medical is a private, pre-revenue medical device company founded in 2009, pioneering a novel ultrasound-based imaging technology called Acoustic Coherent Tomography (ACT). The ACT platform is designed to offer deep-penetration, tomographic images of bone and soft tissue without radiation, targeting the musculoskeletal imaging market as a potential alternative or complement to MRI and CT. The company's initial applications are focused on diagnosing musculoskeletal conditions and providing image guidance for procedures like joint replacements and spine interventions, though its system is not yet commercially available.

Acoustic Coherent Tomography (ACT): An advanced ultrasound-based imaging platform using proprietary coded waveforms, a 180-degree wide-aperture transducer, and tomographic processing algorithms to generate high-resolution, deep-penetration images of bone and soft tissue without ionizing radiation.

Decision Sciences Medical competes in the broad medical imaging market against giants like GE HealthCare, Siemens, Philips, and Canon (MRI/CT), as well as ultrasound leaders like Butterfly Network, Philips (ultrasound), and Fujifilm Sonosite. Its unique value proposition is combining deep-tissue, bone-visualizing capability (typical of CT) with the portability, safety, and cost profile of ultrasound, a niche currently not fully addressed.